Shearman & Sterling advised Great Elm Capital on the deal. Great Elm Capital (Nasdaq: GECC) signed a definitive agreement to complete the formation of its joint venture...
Great Elm Capital’s Joint Venture With Berkadia Commercial Mortgage
Texas Instruments Incorporated’s $800 Million Investment Grade Notes Offering
Davis Polk advised Texas Instruments Incorporated, while Simpson Thacher & Bartlett acted for the underwriters in connection with the offering. Texas Instruments Incorporated (NASDAQ:TXN) announced the...
Waterlogic Group Holdings and Culligan International’s $1.425 Billion Financing for the Combination
Shearman & Sterling advised Morgan Stanley Senior Funding, as Administrative Agent, on the transaction. The transaction consisted in a $1.425 billion incremental financing for the combination of...
Cambrex’s Acquisition of Snapdragon Chemistry
Ropes & Gray advised Cambrex on the deal. Cambrex, a global contract development manufacturing organization (CDMO) providing products and services across the entire drug lifecycle, signed a...
TransAlta’s $400 Million Public Bond Offering
Paul, Weiss advised TransAlta Corporation in the offering. TransAlta Corporation announced its public offering of $400 million of 7.750% green senior unsecured notes due 2029, which...
Audax Private Equity’s Acquisition of Medi-Weightloss
Ropes & Gray represented Audax Private Equity on the deal. Audax Private Equity announced its acquisition of Medi-Weightloss, Inc., an operator of science-based, physician-supervised weight-loss and wellness...
Chart Industries’ $4.4 Billion Acquisition of Howden
Winston & Strawn and Commeo advised Chart, while Paul Weiss, Rifkind, Wharton & Garrison advised KPS Capital Partners, LP and Howden on the deal. KPS Capital...
Deep Water Point’s Acquisition of Wolf Den Associates
Holland & Knight represented Wolf Den Associates on the deal. Wolf Den Associates, a leading consulting firm specializing in full lifecycle growth support to the federal...
CytomX’s Collaboration and Licensing Agreement With Regeneron Pharmaceuticals
Latham & Watkins LLP represented CytomX in the transaction. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and CytomX Therapeutics, Inc. (NASDAQ: CTMX) have announced a collaboration and licensing...
Fizz’s $12 Million Series A Funding Round
Foley & Lardner LLP represented New Enterprise Associates (NEA) on the deal. New Enterprise Associates (NEA) acted the lead investor in the $12 million Series A funding...
Descript’s $50 Million Series C Financing Round
Goodwin Procter advised OpenAI Startup Fund on the deal. OpenAI Startup Fund announced its investment in Descript’s $50 million Series C financing round to support and accelerate...
Caltius Equity Partners’ Investment in APHIX
Faegre Drinker advised Caltius Equity Partners on the deal. Los Angeles-based investment firm Caltius Equity Partners (Caltius) announced its significant investment in APHIX, a founder-owned provider of...